Assoc. Prof. Dr. Ozra Tabatabaei-Malazy, Tehran University of Medical Sciences, Iran.
Dr. Ozra Tabatabaei Malazy is a distinguished researcher and academic in endocrinology and metabolism, associated with the Tehran University of Medical Sciences (TUMS) Endocrinology & Metabolism Research Institute (EMRI). Born in Iran in 1966, Dr. Tabatabaei has dedicated her career to improving clinical and public health outcomes, particularly in diabetes and metabolic disorders. With an impressive h-index of 23 (Scopus) and 33 (Google Scholar), she has contributed significantly to scientific knowledge through her expertise in clinical trials, cross-sectional studies, and meta-analyses. Her academic achievements include an MD, MPH, and PhD in Pharmacology, culminating in her current position as Assistant Professor. Dr. Tabatabaei’s influence extends to editorial roles in prominent journals, reflecting her commitment to advancing research quality and ethics. Her work is characterized by a focus on translating research into effective treatments and preventive measures, particularly for non-communicable diseases prevalent in Iran and worldwide.
Professional Profile
scopus
orcid
google scholar
summary of suitability for Best Researcher Award
Dr. Ozra Tabatabaei Malazy demonstrates an impressive track record in medical research, particularly in endocrinology and metabolism. Her extensive educational background, including an MD, an MPH focused on Knowledge Transfer Exchange, and a PhD in Pharmacology, aligns well with the research and clinical demands of the field. With over two decades of dedicated research experience at Tehran University of Medical Sciences, she has contributed to numerous studies on topics like diabetes, metabolic disorders, oxidative stress, and systematic reviews of therapeutic interventions. Her ongoing involvement in research projects, particularly in clinical trials, cross-sectional studies, and meta-analyses, highlights her commitment to advancing scientific knowledge and clinical practices.
Education
Dr. Tabatabaei Malazy’s educational background underscores her dedication to both medical practice and research. She earned her General Medical Doctor (MD) degree in 1993, providing a strong foundation in clinical medicine. In 2006, she pursued a Master of Public Health (MPH) at Tehran University of Medical Sciences (TUMS), where her dissertation focused on Knowledge Transfer Exchange (KTE), a critical area for implementing research findings into healthcare practice. Driven by her passion for pharmacology and therapeutic interventions, she further advanced her academic qualifications with a PhD in Pharmacology in 2016. These degrees equipped her with the skills to integrate clinical insights with a population health perspective, fostering her development as a versatile researcher. Today, as an Assistant Professor, Dr. Tabatabaei combines her expertise in medicine, public health, and pharmacology to contribute to the fields of endocrinology and metabolism through her research and clinical trials.
Experience
Dr. Tabatabaei has a robust career in endocrinology and metabolism, with over two decades at the Tehran University of Medical Sciences’ Endocrinology & Metabolism Research Institute (EMRI). Since 1998, she has served as a research fellow, contributing to groundbreaking research in diabetes and lipid disorders. Additionally, she has been an active reviewer for journals like Iranian Journal of Diabetes & Lipid Disorders and Plos One, among others. Her influence extends to editorial roles, including Section Editor for the Journal of Diabetes and Metabolic Disorders and Plos One. Dr. Tabatabaei’s contributions are enriched by her membership on EMRI’s peer-review committee and her involvement as a guest editor. These positions showcase her commitment to advancing scientific standards. Through her editorial and peer-review work, Dr. Tabatabaei is shaping the quality of research published in her field, ensuring its relevance and integrity in endocrinology and metabolic sciences.
Awards and Honors
Dr. Tabatabaei’s outstanding contributions to endocrinology and metabolism have earned her numerous awards and honors, recognizing her influence in clinical research. Her editorial appointments across renowned journals such as Plos One and the Journal of Diabetes and Metabolic Disorders underline her authority in the field. Additionally, Dr. Tabatabaei’s role as a guest editor for Frontiers in Endocrinology highlights her expertise and leadership in metabolic research. Her efforts in reviewing and overseeing high-impact research have further contributed to her esteemed status within the academic community. With her impressive h-index metrics—23 in Scopus and 33 in Google Scholar—she is well-regarded for her scholarly impact. Dr. Tabatabaei’s recognitions underscore her commitment to advancing research and influencing global health perspectives, particularly within endocrinology and non-communicable disease prevention.
Research Focus
Dr. Tabatabaei’s research primarily centers on non-communicable diseases, particularly diabetes and metabolic disorders. Her studies explore the underlying mechanisms of these conditions, emphasizing risk factors, preventive measures, and therapeutic interventions. Dr. Tabatabaei has contributed to numerous clinical trials and cross-sectional studies, providing valuable insights into the epidemiology and management of metabolic diseases. Her work often includes systematic reviews and meta-analyses, establishing her as a pivotal figure in evidence-based medicine. Dr. Tabatabaei is also actively involved in scientometric studies that analyze research trends and their impact on healthcare practices. Her commitment to research extends to the field of pharmacology, where she examines the effects of natural and synthetic compounds on metabolic health. Through her extensive research, Dr. Tabatabaei aims to develop practical solutions for managing and mitigating the global burden of diabetes and related metabolic disorders.
Publication Top Notes
-
Title: Nurses’ role in diabetic foot prevention and care; a review
Citation: 259
-
Title: New horizons in treatment of osteoporosis
Citation: 211
-
Title: Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the …
Citation: 185
-
Title: Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in …
Citation: 161
-
Title: Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease .
Citation: 149